Management of Anal Squamous Intraepithelial Lesions

Carlos E Pineda; Mark L Welton

doi:10.1055/s-0029-1223840

Clinics in Colon and Rectal Surgery, Table of Contents

Clin Colon Rectal Surg 2009; 22(2): 094-101
DOI: 10.1055/s-0029-1223840

Management of Anal Squamous Intraepithelial Lesions

Carlos E. Pineda¹ , Mark L. Welton¹

¹Section of Colon and Rectal Surgery, Stanford University School of Medicine, Stanford, California

Abstract

ABSTRACT

Anal squamous intraepithelial lesions include both low-grade squamous intraepithelial lesions (LSIL) and high-grade squamous intraepithelial lesions (HSIL) and are caused by chronic infection with the human papillomavirus (HPV). The disease is increasing in both incidence and prevalence, especially among patients with the following risk factors: homosexual men, acquired or iatrogenic immunosuppression, and presence of other HPV-related diseases. Although the natural history of the disease is unknown, there is significant evidence that untreated HSIL progresses to squamous cell carcinoma in 11% of patients and in up to 50% of patients with extensive disease and immunosuppression. Anal cytology and reflex HPV DNA testing are used to screen for disease, particularly among patients with the aforementioned risk factors. Evaluation of the patient should include physical examination and high-resolution anoscopy (HRA) to evaluate for disease above and below the dentate line. Intervention is warranted and this can be achieved in many ways. The treatment option associated with the best outcomes is ablation directed with HRA, which can be performed in the office or in the operating room with minimal morbidity. This strategy is effective in patients with both low-volume and high-volume disease and is associated with a malignant progression rate of 0.4% in patients with treated HSIL.

KEYWORDS

Anal squamous dysplasia - high-grade squamous intraepithelial lesions - high-resolution anoscopy

Full Text

References

REFERENCES

1 Pineda C E, Welton M L. Controversies in the management of anal high-grade squamous intraepithelial lesions. Minerva Chir. 2008; 63(5) 389-399
2 Apgar B S, Zoschnick L, Wright Jr T C. The 2001 Bethesda System terminology. Am Fam Physician. 2003; 68(10) 1992-1998
3 Longacre T A, Kong C S, Welton M L. Diagnostic problems in anal pathology. Adv Anat Pathol. 2008; 15(5) 263-278
4 Grodsky L. Bowen's disease of the anal region: squamous cell carcinoma in situ; report of three cases. Am J Surg. 1954; 88(5) 710-714
5 Welton M L, Amerhauser A, Litle V R, Leavenworth J D, Darragh T M, Palefsky J M. Anal Bowen's disease and high-grade squamous intraepithelial lesions are histologically and immunohistochemically indistinguishable. , [meeting abstract] Dis Colon Rectum. 2001; 44 A32
6 Fleshner P R, Chalasani S, Chang G J, Levien D H, Hyman N H, Buie W D. Standards Practice Task Force, American Society of Colon and Rectal Surgeons . Practice parameters for anal squamous neoplasms. Dis Colon Rectum. 2008; 51(1) 2-9
6a Edge S B. AJCC Cancer Staging Manual. 7th edition. , In press
7 Varnai A D, Bollmann M, Griefingholt H et al.. HPV in anal squamous cell carcinoma and anal intraepithelial neoplasia (AIN). Impact of HPV analysis of anal lesions on diagnosis and prognosis. Int J Colorectal Dis. 2006; 21(2) 135-142
8 Welton M L, Sharkey F E, Kahlenberg M S. The etiology and epidemiology of anal cancer. Surg Oncol Clin N Am. 2004; 13(2) 263-275
9 Litle V R, Leavenworth J D, Darragh T M et al.. Angiogenesis, proliferation, and apoptosis in anal high-grade squamous intraepithelial lesions. Dis Colon Rectum. 2000; 43(3) 346-352
10 D'Souza G, Wiley D J, Li X et al.. Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr. 2008; 48(4) 491-499
11 Adami J, Gäbel H, Lindelöf B et al.. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer. 2003; 89(7) 1221-1227
12 Stier E A, Krown S E, Chi D S, Brown C L, Chiao E Y, Lin O. Anal dysplasia in HIV-infected women with cervical and vulvar dysplasia. J Low Genit Tract Dis. 2004; 8(4) 272-275
13 Frisch M. On the etiology of anal squamous carcinoma. Dan Med Bull. 2002; 49(3) 194-209
14 Abramowitz L, Benabderrahmane D, Ravaud P et al.. Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women: prevalence and associated factors. AIDS. 2007; 21(11) 1457-1465
15 Sobhani I, Walker F, Roudot-Thoraval F et al.. Anal carcinoma: incidence and effect of cumulative infections. AIDS. 2004; 18(11) 1561-1569
16 Gohy L, Gorska I, Rouleau D HIPVIRG Study Group et al. Genotyping of human papillomavirus DNA in anal biopsies and anal swabs collected from HIV-seropositive men with anal dysplasia. J Acquir Immune Defic Syndr. 2008; 49(1) 32-39
17 Johnson L G, Madeleine M M, Newcomer L M, Schwartz S M, Daling J R. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer. 2004; 101(2) 281-288
18 Cress R D, Holly E A. Incidence of anal cancer in California: increased incidence among men in San Francisco, 1973-1999. Prev Med. 2003; 36(5) 555-560
19 Koblin B A, Hessol N A, Zauber A G et al.. Increased incidence of cancer among homosexual men, New York City and San Francisco, 1978-1990. Am J Epidemiol. 1996; 144(10) 916-923
20 Frisch M, Melbye M, Møller H. Trends in incidence of anal cancer in Denmark. BMJ. 1993; 306(6875) 419-422
21 Ciobotaru B, Leiman G, St John T, Hyman N, Ramundo M, Grace C. Prevalence and risk factors for anal cytologic abnormalities and human papillomavirus infection in a rural population of HIV-infected males. Dis Colon Rectum. 2007; 50(7) 1011-1016
22 Marfing T E, Abel M E, Gallagher D M. Perianal Bowen's disease and associated malignancies. Results of a survey. Dis Colon Rectum. 1987; 30(10) 782-785
23 Devaraj B, Cosman B C. Expectant management of anal squamous dysplasia in patients with HIV. Dis Colon Rectum. 2006; 49(1) 36-40
24 Scholefield J H, Castle M T, Watson N F. Malignant transformation of high-grade anal intraepithelial neoplasia. Br J Surg. 2005; 92(9) 1133-1136
25 Herat A, Shirato K, Damian D L, Finlayson R, Whitfeld M. Invasive squamous cell carcinoma arising in refractory perianal Bowen's disease in a HIV-positive individual. Australas J Dermatol. 2006; 47(2) 120-123
26 Pineda C E, Berry J M, Jay N, Palefsky J M, Welton M L. High resolution anoscopy in the planned staged treatment of anal squamous intraepithelial lesions in HIV-negative patients. J Gastrointest Surg. 2007; 11(11) 1410-1415 discussion 1415-1416 discussion 5-6
27 Kreuter A, Brockmeyer N H, Hochdorfer B et al.. Clinical spectrum and virologic characteristics of anal intraepithelial neoplasia in HIV infection. J Am Acad Dermatol. 2005; 52(4) 603-608
28 Watson A J, Smith B B, Whitehead M R, Sykes P H, Frizelle F A. Malignant progression of anal intra-epithelial neoplasia. ANZ J Surg. 2006; 76(8) 715-717
29 Jay N, Berry J M, Hogeboom C J, Holly E A, Darragh T M, Palefsky J M. Colposcopic appearance of anal squamous intraepithelial lesions: relationship to histopathology. Dis Colon Rectum. 1997; 40(8) 919-928
30 O'Connor J J. The study of anorectal disease by colposcopy. Dis Colon Rectum. 1977; 20(7) 570-572
31 Pineda C E, Berry J M, Welton M L. High resolution anoscopy and targeted treatment of high-grade squamous intraepithelial lesions. Dis Colon Rectum. 2006; 49(1) 126
32 Tramujas da Costa e Silva I, de Lima Ferreira L C, Santos Gimenez F et al.. High-resolution anoscopy in the diagnosis of anal cancer precursor lesions in renal graft recipients. Ann Surg Oncol. 2008; 15(5) 1470-1475
33 Chung A P, Rosenfeld D B. Intraoperative high-resolution anoscopy: a minimally invasive approach in the treatment of patients with Bowen's disease and results in a private practice setting. Am Surg. 2007; 73(12) 1279-1283
34 Cranston R D, Darragh T M, Holly E A et al.. Self-collected versus clinician-collected anal cytology specimens to diagnose anal intraepithelial neoplasia in HIV-positive men. J Acquir Immune Defic Syndr. 2004; 36(4) 915-920
35 Chin-Hong P V, Berry J M, Cheng S C et al.. Comparison of patient- and clinician-collected anal cytology samples to screen for human papillomavirus-associated anal intraepithelial neoplasia in men who have sex with men. Ann Intern Med. 2008; 149(5) 300-306
36 Solomon D, Davey D, Kurman R Forum Group Members et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002; 287(16) 2114-2119
37 Palefsky J M, Holly E A, Hogeboom C J, Berry J M, Jay N, Darragh T M. Anal cytology as a screening tool for anal squamous intraepithelial lesions. J Acquir Immune Defic Syndr Hum Retrovirol. 1997; 14(5) 415-422
38 de Ruiter A, Carter P, Katz D R et al.. A comparison between cytology and histology to detect anal intraepithelial neoplasia. Genitourin Med. 1994; 70(1) 22-25
39 Panther L A, Wagner K, Proper J et al.. High resolution anoscopy findings for men who have sex with men: inaccuracy of anal cytology as a predictor of histologic high-grade anal intraepithelial neoplasia and the impact of HIV serostatus. Clin Infect Dis. 2004; 38(10) 1490-1492
40 Arain S, Walts A E, Thomas P, Bose S. The anal Pap smear: cytomorphology of squamous intraepithelial lesions. Cytojournal. 2005; 2(1) 4
41 Fox P A, Seet J E, Stebbing J et al.. The value of anal cytology and human papillomavirus typing in the detection of anal intraepithelial neoplasia: a review of cases from an anoscopy clinic. Sex Transm Infect. 2005; 81(2) 142-146
42 Nadal S R, Calore E E, Nadal L R, Horta S H, Manzione C R. [Anal cytology for screening of pre-neoplasic lesions]. Rev Assoc Med Bras. 2007; 53(2) 147-151
43 Garcia F U, Haber M M, Butcher J, Sharma M, Nagle D. Increased sensitivity of anal cytology in evaluation of internal compared with external lesions. Acta Cytol. 2007; 51(6) 893-899
44 Cranston R D, Hart S D, Gornbein J A, Hirschowitz S L, Cortina G, Moe A A. The prevalence, and predictive value, of abnormal anal cytology to diagnose anal dysplasia in a population of HIV-positive men who have sex with men. Int J STD AIDS. 2007; 18(2) 77-80
45 Mathews W C, Sitapati A, Caperna J C, Barber R E, Tugend A, Go U. Measurement characteristics of anal cytology, histopathology, and high-resolution anoscopic visual impression in an anal dysplasia screening program. J Acquir Immune Defic Syndr. 2004; 37(5) 1610-1615
46 Lytwyn A, Salit I E, Raboud J et al.. Interobserver agreement in the interpretation of anal intraepithelial neoplasia. Cancer. 2005; 103(7) 1447-1456
47 Scott H, Khoury J, Moore B A, Weissman S. Routine anal cytology screening for anal squamous intraepithelial lesions in an urban HIV clinic. Sex Transm Dis. 2008; 35(2) 197-202
48 Wright Jr T C, Massad L S, Dunton C J, Spitzer M, Wilkinson E J, Solomon D. 2006 ASCCP-Sponsored Consensus Conference . 2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis. 2007; 11(4) 201-222
49 Goldstone S E, Kawalek A Z, Goldstone R N, Goldstone A B. Hybrid Capture II detection of oncogenic human papillomavirus: a useful tool when evaluating men who have sex with men with atypical squamous cells of undetermined significance on anal cytology. Dis Colon Rectum. 2008; 51(7) 1130-1136
50 Walts A E, Thomas P, Bose S. Anal cytology: is there a role for reflex HPV DNA testing?. Diagn Cytopathol. 2005; 33(3) 152-156
51 Papaconstantinou H T, Lee A J, Simmang C L et al.. Screening methods for high-grade dysplasia in patients with anal condyloma. J Surg Res. 2005; 127(1) 8-13
52 Goldie S J, Kuntz K M, Weinstein M C, Freedberg K A, Welton M L, Palefsky J M. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA. 1999; 281(19) 1822-1829
53 Goldie S J, Kuntz K M, Weinstein M C, Freedberg K A, Palefsky J M. Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men. Am J Med. 2000; 108(8) 634-641
54 van Poelgeest M I, van Seters M, van Beurden M et al.. Detection of human papillomavirus (HPV) 16-specific CD4+ T-cell immunity in patients with persistent HPV16-induced vulvar intraepithelial neoplasia in relation to clinical impact of imiquimod treatment. Clin Cancer Res. 2005; 11(14) 5273-5280
55 Wieland U, Brockmeyer N H, Weissenborn S J et al.. Imiquimod treatment of anal intraepithelial neoplasia in HIV-positive men. Arch Dermatol. 2006; 142(11) 1438-1444
56 Kreuter A, Potthoff A, Brockmeyer N H German Competence Network HIV/AIDS et al. Imiquimod leads to a decrease of human papillomavirus DNA and to a sustained clearance of anal intraepithelial neoplasia in HIV-infected men. J Invest Dermatol. 2008; 128(8) 2078-2083
57 Sanclemente G, Herrera S, Tyring S K et al.. Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia. J Eur Acad Dermatol Venereol. 2007; 21(8) 1054-1060
58 Palefsky J M, Berry J M, Jay N et al.. A trial of SGN-00101 (HspE7) to treat high-grade anal intraepithelial neoplasia in HIV-positive individuals. AIDS. 2006; 20(8) 1151-1155
59 Einstein M H, Kadish A S, Burk R D et al.. Heat shock fusion protein-based immunotherapy for treatment of cervical intraepithelial neoplasia III. Gynecol Oncol. 2007; 106(3) 453-460
60 Webber J, Fromm D. Photodynamic therapy for carcinoma in situ of the anus. Arch Surg. 2004; 139(3) 259-261
61 Strauss R J, Fazio V W. Bowen's disease of the anal and perianal area. A report and analysis of twelve cases. Am J Surg. 1979; 137(2) 231-234
62 Marchesa P, Fazio V W, Oliart S, Goldblum J R, Lavery I C. Perianal Bowen's disease: a clinicopathologic study of 47 patients. Dis Colon Rectum. 1997; 40(11) 1286-1293
63 Beck D E, Fazio V W, Jagelman D G, Lavery I C. Perianal Bowen's disease. Dis Colon Rectum. 1988; 31(6) 419-422
64 Margenthaler J A, Dietz D W, Mutch M G, Birnbaum E H, Kodner I J, Fleshman J W. Outcomes, risk of other malignancies, and need for formal mapping procedures in patients with perianal Bowen's disease. Dis Colon Rectum. 2004; 47(10) 1655-1660 discussion 1660-1661 discussion 60-1
65 Brown S R, Skinner P, Tidy J, Smith J H, Sharp F, Hosie K B. Outcome after surgical resection for high-grade anal intraepithelial neoplasia (Bowen's disease). Br J Surg. 1999; 86(8) 1063-1066
66 Colquhoun P, Nogueras J J, Dipasquale B, Petras R, Wexner S D, Woodhouse S. Interobserver and intraobserver bias exists in the interpretation of anal dysplasia. Dis Colon Rectum. 2003; 46(10) 1332-1336 discussion 1336-1338 discussion 6-8
67 Goldstone S E, Kawalek A Z, Huyett J W. Infrared coagulator: a useful tool for treating anal squamous intraepithelial lesions. Dis Colon Rectum. 2005; 48(5) 1042-1054
68 Goldstone S E, Hundert J S, Huyett J W. Infrared coagulator ablation of high-grade anal squamous intraepithelial lesions in HIV-negative males who have sex with males. Dis Colon Rectum. 2007; 50(5) 565-575
69 Cranston R D, Hirschowitz S L, Cortina G, Moe A A. A retrospective clinical study of the treatment of high-grade anal dysplasia by infrared coagulation in a population of HIV-positive men who have sex with men. Int J Std AIDS. 2008; 19(2) 118-120
70 Pineda C E, Berry J M, Jay N, Palefsky J M, Welton M L. High-resolution anoscopy targeted surgical destruction of anal high-grade squamous intraepithelial lesions: a ten-year experience. Dis Colon Rectum. 2008; 51(6) 829-835 discussion 835-837 discussion 35-7
71 Nathan M, Hickey N, Mayuranathan L, Vowler S L, Singh N. Treatment of anal human papillomavirus-associated disease: a long term outcome study. Int J Std AIDS. 2008; 19(7) 445-449

Carlos E PinedaM.D.

Section of Colon and Rectal Surgery, Stanford University School of Medicine

300 Pasteur Dr., Stanford, CA 94305

Email: cepineda@stanford.edu